Spatial analyses revealed distinct immune cell communities in primary and metastatic PDAC, in which cytokeratin 19 (CK19+) cells clustered differentially with αSMA+, CD3+, and CD68+ cells, depending on the tumor site. This evidence concerns the gene KRT19 and neoplasm.